T H E G O L D E N S T A T E
BioBUSINESS NEWS ™
B I O M E D I C A L B U S I N E S S N E W S L E T T E R S I N C E 1 9 8 7
| Bonus Features | ||
Bonus FeaturesClick here to download PDF files of reprints of some of our most popular articles.
Provided courtesy of ChinaBio™ Today (http://www.chinabiotoday.com/).
Vol X Issue 10: November/December 2007 (Contents)
Follow-on Biologics Revisited: Who's on First? by Greg Scott, Managing Editor
Click here to download a presentation on generics given by Frank L. Douglas, PhD, MD at the 11th Annual Healthcare Industry Forum in Bejing.
Vol X Issue 7: July/August 2007 (Contents)
Factoids: 2007 Global Report on High-Growth Entrepreneurship
Click here to download this report from the Global Entrepreneurship Monitor (GEM) consortium which details the state of entrepreneurship throughout the world.
Vol X Issue 4: April 2007 (Contents)
Partnering with Big Pharma: How to Structure a Successful Agreement
by Glen Sato, Partner, Cooley Goodward Kronish LLP, and Greg B. Scott, Managing Editor
Download a term sheet template for a partnering agreement (provided by Glen Sato of Cooley Goodward)
Vol IX Issue 3: November/December 2006 (Contents)
Hypertension: Its Arbitrary Definition and Haphazard Diagnosis
by Frank H. Eeckman, MD, PhD, Science Editor
Hypertension is defined by a specific level of blood pressure, measured the same way it has been for 50 years - manually with an inflatable cuff device. The diagnosis for this disease is typically based on a single reading, even though blood pressure can vary greatly. We look at hypertension, the biggest market for pharmaceuticals... Read more...
Vol IX Issue 2: October 2006 (Contents)
Athenagen Raises $50 Million is Series B Funding.
September 22, 2006, South San Francisco, CA - Athenagen closed its B round today, raising a total of $50 million total from Clarus, Sanderling, Index, Charter and others. Download the press release. (Courtesy of Life Science Angels.)
The Importance of Angiogenesis
by Frank H. Eeckman, MD, PhD, Science Editor
Angiogenesis was first described in 1787 but it wasn't until nearly 200 years later that Dr. Judah Folkman hypothesized angiogenesis played a crucial role in disease processes. We look at how understanding this process has helped drug makers discover new compounds to treat previously intractable diseases... Read more...
Vol IX Issue 1: September 2006 (Contents)
Novocell Attacks Diabetes with Stem Cells
In type I diabetes, patients lose their insulin producing beta cells due to an immune process. Novocell will soon begin clinical trials using stem cell-based therapy that could mean years between injections. BBN's science editor, Dr. Frank Eeckman, interviews Dr. Edward Baetge, Novocell's Chief Scientific officer. Read more...
|
||